Metabolic syndrome and insulin resistance in migraine
- PMID: 22278639
- PMCID: PMC3356472
- DOI: 10.1007/s10194-012-0416-y
Metabolic syndrome and insulin resistance in migraine
Abstract
Metabolic syndrome is associated with migraine but there is no study comparing the characteristics of migraine with and without metabolic syndrome from Southeast Asia. This study was therefore undertaken to compare the clinical characteristics of migraine in patients with and without metabolic syndrome and insulin resistance. 135 consecutive patients with migraine diagnosed on the basis of International Headache Society criteria were subjected to clinical evaluation as per fixed protocol. Headache severity, frequency and functional disability were recorded. Metabolic syndrome was diagnosed as per National Cholesterol Education Programme: Adult Treatment Panel III and International Diabetic Federation criteria. Insulin resistance was calculated by homeostases model assessment. Their age ranged between 14 and 61 years and 108 were females. Metabolic syndrome was present in 31.9% patients and only 13 were obese. Insulin resistance was present in 11.1%. Metabolic syndrome was correlated with age, gender, number of triggers, years of headache and duration of migraine attacks. Insulin resistance correlated with duration of migraine attacks. From this study, it can be concluded that metabolic syndrome was present in 31.9% of the migraineurs which was mainly in elderly who had longer duration of headache and multiple triggers.
Similar articles
-
The potential impact of insulin resistance and metabolic syndrome on migraine headache characteristics.BMC Neurol. 2022 Nov 12;22(1):422. doi: 10.1186/s12883-022-02966-x. BMC Neurol. 2022. PMID: 36368970 Free PMC article.
-
Chronic migraine in women is associated with insulin resistance: a cross-sectional study.Eur J Neurol. 2014 Feb;21(2):267-72. doi: 10.1111/ene.12289. Epub 2013 Nov 15. Eur J Neurol. 2014. PMID: 24238370
-
Migraine, headache and development of metabolic syndrome: an 11-year follow-up in the Nord-Trøndelag Health Study (HUNT).Pain. 2013 Aug;154(8):1305-11. doi: 10.1016/j.pain.2013.04.007. Epub 2013 Apr 8. Pain. 2013. PMID: 23726372
-
Migraine in metabolic syndrome.Neurologist. 2009 Mar;15(2):55-8. doi: 10.1097/NRL.0b013e31817781b6. Neurologist. 2009. PMID: 19276782
-
Migraine, Brain Glucose Metabolism and the "Neuroenergetic" Hypothesis: A Scoping Review.J Pain. 2022 Aug;23(8):1294-1317. doi: 10.1016/j.jpain.2022.02.006. Epub 2022 Mar 14. J Pain. 2022. PMID: 35296423
Cited by
-
Pathophysiological Bases of Comorbidity in Migraine.Front Hum Neurosci. 2021 Apr 20;15:640574. doi: 10.3389/fnhum.2021.640574. eCollection 2021. Front Hum Neurosci. 2021. PMID: 33958992 Free PMC article. Review.
-
The potential impact of insulin resistance and metabolic syndrome on migraine headache characteristics.BMC Neurol. 2022 Nov 12;22(1):422. doi: 10.1186/s12883-022-02966-x. BMC Neurol. 2022. PMID: 36368970 Free PMC article.
-
Comparison of physical activity levels and dietary habits between women with polycystic ovarian syndrome and healthy controls of reproductive age: a case-control study.BMC Womens Health. 2024 Jan 8;24(1):29. doi: 10.1186/s12905-023-02866-3. BMC Womens Health. 2024. PMID: 38191428 Free PMC article.
-
Association of diet and headache.J Headache Pain. 2019 Nov 14;20(1):106. doi: 10.1186/s10194-019-1057-1. J Headache Pain. 2019. PMID: 31726975 Free PMC article. Review.
-
High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.J Neurol. 2013 Nov;260(11):2793-801. doi: 10.1007/s00415-013-7072-2. Epub 2013 Aug 21. J Neurol. 2013. PMID: 23963471 Clinical Trial.
References
-
- Brennum J, Brinck T, Schriver L, et al. Sumatriptan has no clinically relevant effect in the treatment of episodic tension type headache. Eur J Neurol. 1996;3:23–28. doi: 10.1111/j.1468-1331.1996.tb00184.x. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical